Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
Condition: Carcinoma, Renal Cell, Diagnostic Imaging, Pathology, Deep Learning
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT07166445
Sponsor: Peking University First Hospital
Phase:
Eligibility:
- Age: minimum 18 Years maximum 85 Years
- Gender: All
Inclusion Criteria:
- Histopathologically confirmed renal cell carcinoma on postoperative specimen.
- Preoperative contrast-enhanced CT performed at our institution with slice thickness ≤ 1 mm and complete DICOM datasets.
- Postoperative pathologic staging clearly defined as pT1a-T2b or pT3a.
- CT image quality deemed adequate for analysis.
Exclusion Criteria:
- 1. Pathologic subtype other than RCC. 2. Images with severe artifacts.
View trial on ClinicalTrials.gov